All biotech firms depend on their intellectual property rights. Their IP rights, often patents, will either be a result of the firm's own R&D or they may have been bought or licensed in from another party. In addition to establishing rights, biotech firms in particular often need to perform IP due diligence analyses to establish the exact scope and value of their IPR e.g. when they seek new investors or in connection with licensing agreements.
Patenting of biotech inventions offers special challenges, which require an updated knowledge on special patent case law in Europe.
Plougmann & Vingtoft will help you do all this. We have often been known as pioneers in the field of biotech patents and we have a long-standing tradition of providing intellectual property consulting to the biotech industry throughout Europe.
You can contact one of our IPR experts listed below for more information on patenting of biotechnological inventions or fill out this contact form with your enquiry and we will get back to you as soon as possible.
Our IPR experts in the field of biotechnology:
Bojan Savic
Camilla Kiørboe
Jakob Schwalbe Lohmann
Jan Mondrup Pedersen
Katja Sørensen
Kim Wagner
Lars Hallander
Michael Schandorf Sørensen
Mikkel Dalkiær
Nicka Kirstejn
Per Larsen
Pernille Elmedyb
Søren Boye
.gif)
|
